SIGHTSTREAM Trademark

Trademark Overview

On Friday, April 29, 2022, a trademark application was filed for SIGHTSTREAM with the United States Patent and Trademark Office. The USPTO has given the SIGHTSTREAM trademark a serial number of 97388809. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, September 24, 2024. This trademark is owned by KERA THERAPEUTICS INC.. The SIGHTSTREAM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
sightstream

General Information

Serial Number97388809
Word MarkSIGHTSTREAM
Filing DateFriday, April 29, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements

Pseudo MarkSIGHT STREAM
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 4, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKERA THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052
Party NameKERA THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052

Trademark Events

Event DateEvent Description
Tuesday, May 3, 2022NEW APPLICATION ENTERED
Wednesday, May 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 16, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 25, 2024SOU EXTENSION 2 FILED
Monday, March 25, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2023SOU EXTENSION 1 FILED
Monday, September 25, 2023SOU EXTENSION 1 GRANTED
Monday, October 23, 2023ASSIGNED TO EXAMINER
Tuesday, September 24, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2024SOU EXTENSION 3 FILED
Tuesday, September 24, 2024SOU EXTENSION 3 GRANTED

Related Keywords

sightstream fields biotechnology pharmaceutical development research